ZA200302911B - Method and composition for treatment of ocular hypertension and glaucoma. - Google Patents
Method and composition for treatment of ocular hypertension and glaucoma.Info
- Publication number
- ZA200302911B ZA200302911B ZA200302911A ZA200302911A ZA200302911B ZA 200302911 B ZA200302911 B ZA 200302911B ZA 200302911 A ZA200302911 A ZA 200302911A ZA 200302911 A ZA200302911 A ZA 200302911A ZA 200302911 B ZA200302911 B ZA 200302911B
- Authority
- ZA
- South Africa
- Prior art keywords
- glaucoma
- treatment
- composition
- ocular hypertension
- ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31411001P | 2001-08-23 | 2001-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200302911B true ZA200302911B (en) | 2003-10-14 |
Family
ID=23218598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200302911A ZA200302911B (en) | 2001-08-23 | 2003-04-14 | Method and composition for treatment of ocular hypertension and glaucoma. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030060511A1 (ko) |
EP (1) | EP1420793A1 (ko) |
JP (1) | JP2004521960A (ko) |
KR (1) | KR20040029012A (ko) |
CN (1) | CN1575178A (ko) |
AR (1) | AR036276A1 (ko) |
BR (1) | BR0205932A (ko) |
CA (1) | CA2458230A1 (ko) |
MX (1) | MXPA04001604A (ko) |
NO (1) | NO20031779L (ko) |
WO (1) | WO2003018025A1 (ko) |
ZA (1) | ZA200302911B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005519978A (ja) * | 2002-03-28 | 2005-07-07 | スキャンポ・アーゲー | 高眼圧症および緑内障の処置方法 |
US20040225014A1 (en) * | 2003-02-14 | 2004-11-11 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2694077A4 (en) | 2011-04-07 | 2015-01-21 | Sucampo Ag | METHOD FOR TREATING ASTHENOPY |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932389A (en) * | 1974-12-11 | 1976-01-13 | Pfizer Inc. | 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins |
US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
US6187813B1 (en) * | 1990-04-10 | 2001-02-13 | Pharmacia & Upjohn Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5321128A (en) * | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
ATE101342T1 (de) * | 1988-09-06 | 1994-02-15 | Kabi Pharmacia Ab | Prostaglandinderivate zur behandlung des gruenen stars oder einer okularen hypertension. |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5194429A (en) * | 1988-10-01 | 1993-03-16 | K.K. Ueno Seiyaku Oyo Kenkyujo | Ocular hypotensive agents |
ATE111736T1 (de) * | 1988-10-01 | 1994-10-15 | R Tech Ueno Ltd | Okulare hypotensive mittel. |
TW224942B (ko) * | 1990-04-04 | 1994-06-11 | Adka Ueno Kk | |
ATE114470T1 (de) * | 1990-05-22 | 1994-12-15 | R Tech Ueno Ltd | Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung. |
CA2046069C (en) * | 1990-07-10 | 2002-04-09 | Ryuji Ueno | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
AU687906B2 (en) * | 1993-12-15 | 1998-03-05 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
AU7680096A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
US6458836B1 (en) * | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
US20020035148A1 (en) * | 2000-07-20 | 2002-03-21 | Ryuji Ueno | Treatment of ocular hypertension |
-
2002
- 2002-08-22 MX MXPA04001604A patent/MXPA04001604A/es unknown
- 2002-08-22 KR KR10-2004-7002670A patent/KR20040029012A/ko not_active Application Discontinuation
- 2002-08-22 EP EP02760691A patent/EP1420793A1/en not_active Withdrawn
- 2002-08-22 WO PCT/JP2002/008446 patent/WO2003018025A1/en not_active Application Discontinuation
- 2002-08-22 AR ARP020103150A patent/AR036276A1/es unknown
- 2002-08-22 CN CNA028209214A patent/CN1575178A/zh active Pending
- 2002-08-22 US US10/224,923 patent/US20030060511A1/en not_active Abandoned
- 2002-08-22 JP JP2003522543A patent/JP2004521960A/ja not_active Withdrawn
- 2002-08-22 CA CA002458230A patent/CA2458230A1/en not_active Abandoned
- 2002-08-22 BR BR0205932-0A patent/BR0205932A/pt not_active Application Discontinuation
-
2003
- 2003-04-14 ZA ZA200302911A patent/ZA200302911B/xx unknown
- 2003-04-22 NO NO20031779A patent/NO20031779L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0205932A (pt) | 2004-02-17 |
CN1575178A (zh) | 2005-02-02 |
JP2004521960A (ja) | 2004-07-22 |
MXPA04001604A (es) | 2004-07-08 |
EP1420793A1 (en) | 2004-05-26 |
NO20031779D0 (no) | 2003-04-22 |
NO20031779L (no) | 2003-04-22 |
US20030060511A1 (en) | 2003-03-27 |
CA2458230A1 (en) | 2003-03-06 |
AR036276A1 (es) | 2004-08-25 |
KR20040029012A (ko) | 2004-04-03 |
WO2003018025A1 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2402674B (en) | Compositions and methods for the treatment of glaucoma or ocular hypertension | |
AUPR638101A0 (en) | Composition and method for treatment of disease | |
AU2002305278A1 (en) | Bifurcatable trabecular shunt for glaucoma treatment | |
AU2002236438A1 (en) | Compositions and methods for treatment of mild cognitive impairment | |
EP1414464A4 (en) | METHOD OF TREATING GLAUCOMA | |
EP1392292A4 (en) | PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT | |
IL160037A0 (en) | Method and intra sclera implant for treatment of glaucoma and presbyopia | |
PL377172A1 (pl) | Kompozycje do oczu do leczenia nadciśnienia śródgałkowego | |
EP1515722A4 (en) | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | |
MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
EP1581503A4 (en) | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | |
WO2004028451A3 (en) | β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA | |
EP1515721A4 (en) | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | |
EP1455780A4 (en) | NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA | |
ZA200302911B (en) | Method and composition for treatment of ocular hypertension and glaucoma. | |
NO20035043D0 (no) | Fremgangsmåte for behandling av okular hypertensjon og glaukom | |
ZA200309642B (en) | Benzo (G) quinoline derivatives for treating glaucoma and myopia. | |
AU2002246117A1 (en) | Method for treatment and diagnosis of eye tissues | |
AU4114301A (en) | Treatment of ocular hypertension and glaucoma | |
AU2003215820A8 (en) | Method for treating ocular hypertension and glaucoma | |
AU2002322769A1 (en) | Method for treatment of ocular hypertension and glaucoma | |
AU2001270642A1 (en) | Method for the treatment of glaucoma and ocular hypertension by administering nucleotides | |
AU2003216547A8 (en) | Compositions and methods for treating glaucoma and ocular hypertension | |
AU2001216038A1 (en) | Treatment of glaucoma and ocular hypertension | |
AU2002330974A1 (en) | Method and intra sclera implant for treatment of glaucoma and presbyopia |